Mark White
Corporate Officer/Principal chez ROCKET PHARMACEUTICALS, INC.
Fortune : 2 M $ au 31/05/2024
Profil
Mark White is a Member at The Royal College of Physicians and a Member at the Faculty of Pharmaceutical Medicine.
He is also the General Manager-Commercial Affairs at Rocket Pharmaceuticals, Inc. Mark previously worked at AstraZeneca PLC as the Global Franchise Head-Fasenra.
He completed his undergraduate degree at The University of Manchester.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 08/04/2024 | 75 226 ( 0,08% ) | 2 M $ | 31/05/2024 |
Postes actifs de Mark White
| Sociétés | Poste | Début |
|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Corporate Officer/Principal | 26/03/2024 |
| The Royal College of Physicians | Corporate Officer/Principal | - |
| Faculty of Pharmaceutical Medicine | Corporate Officer/Principal | - |
Anciens postes connus de Mark White
| Sociétés | Poste | Fin |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/04/2023 |
Formation de Mark White
| The University of Manchester | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
| Faculty of Pharmaceutical Medicine |
